- Home
- ACIU vs FXNC Comparison
ACIU vs FXNC Comparison
Compare ACIU & FXNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- FXNC
- Stock Information
- Founded
- ACIU 2003
- FXNC 1907
- Country
- ACIU Switzerland
- FXNC United States
- Employees
- ACIU N/A
- FXNC N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- FXNC Major Banks
- Sector
- ACIU Health Care
- FXNC Finance
- Exchange
- ACIU Nasdaq
- FXNC Nasdaq
- Market Cap
- ACIU 213.3M
- FXNC 185.6M
- IPO Year
- ACIU 2016
- FXNC N/A
- Fundamental
- Price
- ACIU $2.14
- FXNC $21.30
- Analyst Decision
- ACIU Strong Buy
- FXNC Strong Buy
- Analyst Count
- ACIU 1
- FXNC 1
- Target Price
- ACIU $12.00
- FXNC $21.00
- AVG Volume (30 Days)
- ACIU 162.6K
- FXNC 19.0K
- Earning Date
- ACIU 08-05-2025
- FXNC 07-30-2025
- Dividend Yield
- ACIU N/A
- FXNC 2.95%
- EPS Growth
- ACIU N/A
- FXNC N/A
- EPS
- ACIU N/A
- FXNC 0.96
- Revenue
- ACIU $36,362,036.00
- FXNC $72,055,000.00
- Revenue This Year
- ACIU N/A
- FXNC $56.30
- Revenue Next Year
- ACIU $533.21
- FXNC $5.74
- P/E Ratio
- ACIU N/A
- FXNC $21.95
- Revenue Growth
- ACIU 86.71
- FXNC 47.03
- 52 Week Low
- ACIU $1.43
- FXNC $16.22
- 52 Week High
- ACIU $3.98
- FXNC $26.97
- Technical
- Relative Strength Index (RSI)
- ACIU 49.10
- FXNC 56.51
- Support Level
- ACIU $2.05
- FXNC $20.78
- Resistance Level
- ACIU $2.50
- FXNC $22.50
- Average True Range (ATR)
- ACIU 0.20
- FXNC 0.48
- MACD
- ACIU -0.03
- FXNC -0.10
- Stochastic Oscillator
- ACIU 20.00
- FXNC 30.23
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.